N-((3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-AMINOETHYLAMINO)-3-((R)-3-AMINO-1-HYDROXYPROPYL)-6-((1S,2S)-1,2-DIHYDROXY-2-(P-HYDROXYPHENYL)ETHYL)-11,20,25-TRIHYDROXY-15-(HYDROXYMETHYL)-2,5,8,14,17,23-HEXAOXO-1,4,7,13,16,22-HEXAAZATRICYCLO(22.3.0.09,13)HEPTACOS-18-YL)(10R,12S)-10,12-DIMETHYLTETRADECANAMIDE
UNII 3UF9RG9AFQ

Substance Identification & Data

This profile provides standardized clinical and technical data for N-((3s,6s,9s,11r,15s,18s,20r,21s,24s,25s)-21-(2-aminoethylamino)-3-((r)-3-amino-1-hydroxypropyl)-6-((1s,2s)-1,2-dihydroxy-2-(p-hydroxyphenyl)ethyl)-11,20,25-trihydroxy-15-(hydroxymethyl)-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo(22.3.0.09,13)heptacos-18-yl)(10r,12s)-10,12-dimethyltetradecanamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3UF9RG9AFQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1202167-57-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3UF9RG9AFQ
CAS Registry Number
1202167-57-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
N-((3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-AMINOETHYLAMINO)-3-((R)-3-AMINO-1-HYDROXYPROPYL)-6-((1S,2S)-1,2-DIHYDROXY-2-(P-HYDROXYPHENYL)ETHYL)-11,20,25-TRIHYDROXY-15-(HYDROXYMETHYL)-2,5,8,14,17,23-HEXAOXO-1,4,7,13,16,22-HEXAAZATRICYCLO(22.3.0.09,13)HEPTACOS-18-YL)(10R,12S)-10,12-DIMETHYLTETRADECANAMIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C51H86N10O15
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
GINOBWNPZWJLMW-UOHQDOHQSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
44610345
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O=C1N2[C@](C(=O)N[C@H](NCCN)[C@H](O)C[C@H](NC(CCCCCCCC[C@H](C[C@H](CC)C)C)=O)C(=O)N[C@@H](CO)C(=O)N3[C@](C(=O)N[C@@]([C@@H]([C@@H](O)c4ccc(O)cc4)O)(C(=O)N[C@]1([C@@H](CCN)O)[H])[H])(C[C@@H](O)C3)[H])([C@@H](O)CC2)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-((3s,6s,9s,11r,15s,18s,20r,21s,24s,25s)-21-(2-aminoethylamino)-3-((r)-3-amino-1-hydroxypropyl)-6-((1s,2s)-1,2-dihydroxy-2-(p-hydroxyphenyl)ethyl)-11,20,25-trihydroxy-15-(hydroxymethyl)-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo(22.3.0.09,13)heptacos-18-yl)(10r,12s)-10,12-dimethyltetradecanamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CASPOFUNGIN IMPURITY A

Systematic Nomenclature

L-PROLINE, (4R,5S)-5-((2-AMINOETHYL)AMINO)-N2-((10R,12S)-10,12-DIMETHYL-1-OXOTETRADECYL)-4-HYDROXY-L-ORNITHYL-L-SERYL-(4R)-4-HYDROXY-L-PROLYL-(4S)-4-HYDROXY-4-(4-HYDROXYPHENYL)-L-THREONYL-(3R)-3-HYDROXY-L-ORNITHYL-3-HYDROXY-, (6->15)-LACTAM, (3S)-
N-((3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-AMINOETHYLAMINO)-3-((R)-3-AMINO-1-HYDROXYPROPYL)-6-((1S,2S)-1,2-DIHYDROXY-2-(P-HYDROXYPHENYL)ETHYL)-11,20,25-TRIHYDROXY-15-(HYDROXYMETHYL)-2,5,8,14,17,23-HEXAOXO-1,4,7,13,16,22-HEXAAZATRICYCLO(22.3.0.09,13)HEPTACOS-18-YL)(10R,12S)-10,12-DIMETHYLTETRADECANAMIDE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound